Imagine a world where bacteria, typically feared for causing disease, are turned into powerful weapons against cancer. That's ...

A cancer charity has said it is "angry and frustrated" that ministers and health officials have not approved the provision of ...

I knew I was kind of a guinea pig, but the only other option was staying at home, and I wasn’t going to make it,” Tim Story ...

Six months after publicly revealing his “incurable” cancer diagnosis to the nation, Nigel Latta has said he’s responded well ...

The inquiry is the latest effort by the European Commission and European countries to scrutinize potential antitrust behavior ...

Scientists from the University of Auckland have discovered that a cancer drug called alpelisib may help extend lifespan—at ...

AbbVie has pointed to a very strong launch trajectory for Elahere, with sales rocketing to $480 million last year, almost ...

While PD-1/PD-L1 blockade has demonstrated remarkable clinical successes, recent studies suggest that its novel target has a ...

The company has asked the U.S. patent office to reconsider patents that could prevent it from selling an update to Keytruda.

Researchers have identified a previously unknown bacterial protein, the structure of which is being used in the design of protein nanoparticles for the targeted delivery of anticancer drugs to tumors.

Shilpa Medicare soared 10.46% to Rs 696.15 after the company's wholly owned subsidiary, Shilpa Biologicals, inked a strategic partnership with Switzerland-based mAbTree Biologics AG to co-develop and ...